Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene

Journal of Clinical Investigation

Volumn 101, Issue 5, 1998, Pages 956-960

  Tahvanainen, Esa ^a   Syvänne, Mikko ^b   Frick, M Heikki ^b   Murtomäki Repo, Sanna ^a   Antikainen, Marjatta ^a,c   Kesäniemi, Y Antero ^d   Kauma, Heikki ^d   Pasternak, Amos ^e   Taskinen, Marja Riitta ^b   Ehnholm, Christian ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Hepatic lipase activity; High density lipoproteins; LIPC; Polymorphism

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 2642714137     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1144     Document Type: Article

References (44)

1. Ehnholm, C., W. Shaw, H. Greten, and W.V. Brown. 1975. Purification from human plasma of heparin-released lipase with activity against triglyceride and phospholipids. J. Biol. Chem. 250:6756-6761.
2. Ehnholm, C., and T. Kuusi. 1986. Preparation, characterization, and measurement of hepatic lipase. Methods Enzymol. 129:716-738.
3. Semenkovich, C.F., S.-H. Chen, M. Wims, C.-C. Luo, W.-H. Li, and L. Chan. 1989. Lipoprotein lipase and hepatic lipase mRNA tissue specific expression, developmental regulation, and evolution. J. Lipid Res. 30:423-431.
4. Verhoeven, A.J.M., and H. Jansen. 1994. Hepatic lipase mRNA is expressed in rat and human steroidogenic organs. Biochim. Biophys. Acta. 1211: 121-124.
5. Kounnas, M.Z., D.A. Chappell, H. Wong, W.S. Argraves, and D.K. Strickland. 1995. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J. Biol. Chem. 270:9307-9312.
6. Cai, S.-J., D.M. Wong, S.-H. Chen, and L. Chan. 1989. Structure of the human hepatic triglyceride lipase gene. Biochemistry. 28:8966-8971.
7. Ameis, D., G. Stahnke, J. Kobayashi, J. Mclean, G. Lee, M. Büscher, M.C. Schotz, and H. Will. 1990. Isolation and characterization of the human hepatic lipase gene. J. Biol. Chem. 265:6552-6555.
8. Hegele, R.A., L. Tu, and P.W. Connelly. 1992. Human hepatic lipase mutations and polymorphisms. Hum. Mutat. 1:320-324.
9. Knudsen, P., M. Antikainen, S. Ehnholm, M. Uusi-Oukari, H. Tenkanen, S. Lahdenperä, J. Kahri, M. Tilly-Kiesi, A. Bensadoun, M.-R. Taskinen, and C. Ehnholm. 1996. A compound heterozygote for hepatic lipase gene mutations Leu334-Phe and Thr383Met: correlation between hepatic lipase activity and phenotypic expression. J. Lipid Res. 37:825-834.
10. Knudsen, P., M. Antikainen, M. Uusi-Oukari, S. Ehnholm, S. Lahdenperä, A. Bensadoun, H. Funke, H. Wiebusch, G. Assmann, M.-R. Taskinen, and C. Ehnholm. 1997. Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis. 128:165-174.
11. Brand, K., K.A. Dugi, J.D. Brunzell, D.N. Nevin, and S. Santamarina-Fojo. 1996. A novel A-G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J. Lipid Res. 37:1213-1223.
12. Hegele, R.A., J.A. Little, C. Vezina, G. Maguire, L. Tu, T. Wolever, D.J.A. Jenkins, and P.W. Connelly. 1993. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13: 720-728.
13. Breckenridge, W.C., J.A. Little, P. Alaupovic, C.S. Wang, A. Kuksis, G. Kakis, F. Lindgren, and G. Gardiner. 1982. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis. 45:161-179.
14. Auwerx, J.H., S.P. Babirak, J.E. Hokanson, G. Stahnke, H. Will, S.S. Deeb, and J.D. Brunzell. 1990. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am. J. Hum. Genet. 46:470-477.
15. Connelly, P.W., G.F. Maguire, M. Lee, and J.A. Little. 1990. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis. 10:40-48.
16. Takagi, A., Y. Ikeda, A. Mori, Y. Ashida, and A. Yamamoto. 1996. Identification of a BstNI polymorphism in exon 9 of the human hepatic triglyceride lipase gene. Mol Cell. Probes. 10:313-314.
17. Mori, A., A. Takagi, Y. Ikeda, Y. Ashida, and A. Yamamoto. 1996. An Avall polymorphism in exon 5 of the human hepatic triglyceride lipase gene. Mol. Cell. Probes. 10:309-311.
18. Hegele, R.A., J.A. Little, and P.W. Connelly. 1991. Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency. Biochern. Biophys. Res. Commun. 179:78-84.
19. Jansen, H., A.J.M Verhoeven, D.J.J. Halley, and J.D. Kastelein. 1996. C-T substitution at -480 of the hepatic lipase (HL) promoter associated with a lowered HL activity (abstract). The 66th Congress of the European Atherosclerosis Society, July 13-17,Florence, Italy. pp. 20.
20. Murtomäki, S., E. Tahvanainen, M. Antikainen, L. Tiret, V. Nicaud, H. Jansen, and C. Ehnholm. 1997. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. Arterioscler. Thromb. Vasc. Biol. 17:1879-1884.
21. Guerra, R., J. Wang, S.M. Grundy, and J.C. Cohen. 1997. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94:4532-4537.
22. Syvänne, M., M.-R. Taskinen, M.S. Nieminen, V. Manninen. Y.A. Kesäniemi, A. Pasternack, and M.H. Frick. 1997. A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT study. Controlled Clin. Trials. 18:93-119.
23. The EARS Group. 1994. The European Atherosclerosis research study (EARS): design and objectives. Int. J. Epidemiol. 23:465-471.
24. Miller, S.A., D.D. Dykes, and H.F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
25. Syvänen, A.C., A. Sajantila, and M. Lukka. 1993. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am. J. Hum. Genet. 52:46-59.
26. Huttunen, J.K., C. Ehnholm, P.K.J. Kinnunen, and E.A. Nikkilä. 1975. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin. Chim. Acta. 63:335-347.
27. Groener, J.E.M., R.W. Pelton, and G.M. Kostner. 1986. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin. Chem. 32:283-286.
28. Slatking, M., and L. Excoffier. 1996. Testing for linkage disequilibrium in genotypic data using the EM algorithm. Heredity. 76:377-383.
29. Guo, S., and E. Thompson. 1992. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 48:361-372.
30. MacLean, C.J., and N.E. Morton. 1985. Estimation of MYRIAD haplotype frequencies. Genet. Epidemiol. 2:263-272.
31. Schneider, S., J.-M. Kueffer, D. Roessli, and L. Excoffier. 1996. Arlequin: a software package for population genetics. Genetics and Biometry Laboratory. Department of Anthropology, University of Geneva. 82 pp.
32. Nikkilä, E. 1953. Studies on the lipid-protein relationships in normal and pathologic sera and the effect of heparin on serum lipoproteins. Scand. J. Clin. Lab. Invest. 5(Suppl.):1-101.
33. Miller, G.J., and N.E. Miller. 1975. Plasma high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet. 1:16-19.
34. Gordon, T., W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber. 1977. High density lipoproteins as a protective factor against coronary heart disease. The Framingham study. Am. J. Med. 62:707-714.
35. Tall, A.R. 1990. Plasma HDL metabolism and relationship to atherogenesis. J. Clin. Invest. 86:379-384.
36. Kuusi, T., C. Ehnholm, J. Viikari, R. Härkönen, E. Vartiainen, P. Puska, and M.-R. Taskinen. 1989. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J. Lipid Res. 30: 1117-1126.
37. Blades, B., G.L. Vega, and S.M. Grundy. 1993. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler. Thromb. 13:1227-1235.
38. Cohen, J.C., Z. Wang, S.M. Grundy, M.R. Stoesz, and R. Guerra. 1994. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94:2377-2384.
39. Katzel, L.I., P.J. Coon, J. Bushy, S.O. Gottlieb, R.M. Krauss, and A.P. Goldberg. 1992. Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler. Thromb. 12:814-823.
40. Zambon, A., M.A. Austin, B.G. Brown, J.E. Hokanson, and J.D. Brunzell. 1992. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler. Thromb. 13:147-153.
41. Busch, S., R.L. Barnhart, G.A. Martin, M.C. Fitzgerald, M.T. Yates, S.J.T. Mao, C.E. Thomas, and R.L. Jackson. 1994. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in chlolesterol-fed transgenic mice. J. Biol. Chem. 23:16376-16382.
42. Dugi, K.A., I.M. Feuerstein, S. Hill, J. Shih, S. Santamarina-Fojo, H.B. Brewer, Jr., and J.M. Hoeg. 1997. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17:354-364.
43. Hadzopoulou-Cladaras, M., and P. Cardot. 1993. Identification of a cisacting negative element which modulates human hepatic triglyceride lipase gene expression. Biochemistry. 32:9657-9667.
44. Oka, K., K. Ishimura-Oka, M.-J. Chu, and L. Chan. 1996. Transcription of the human hepatic lipase gene is modulated by multiple negative elements in HepG2 cells. Gene (Amst.). 180:69-80.